Funding for this research was provided by:
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (FORTE 2019-01101)
Received: 12 April 2022
Accepted: 17 June 2022
First Online: 24 June 2022
: The study was conducted in accordance with the guiding ethical principles for research in humanities and social sciences established by the Swedish Research Council and was approved by the Swedish Ethical Review Authority [2020–04474]. All informants gave their informed consent before being interviewed.
: Not applicable.
: LSa is a member of The New Therapies Council (a policy-making board in the Swedish healthcare system) and makes decision on whether to recommend new treatments or not. Other than that, the authors declare that they have no competing interests.